Home › Funds › Parametrica Management Ltd › IOVA
Parametrica Management Ltd position in IOVA
IOVANCE BIOTHERAPEUTICS INC · Health Care
Parametrica Management Ltd reported holding 195,878 shares of IOVA (IOVANCE BIOTHERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$815K, representing 0.64% of its reported portfolio and ranking #18 among its reported holdings. Parametrica Management Ltd has disclosed IOVA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Parametrica Management Ltd's IOVA position evolved
Parametrica Management Ltd first disclosed a stake in IOVA in Q3 2023 at 95,400 shares (US$434K). The position peaked in Q4 2023 at 320,276 shares, worth US$2.6M. Across 12 filings, Parametrica Management Ltd increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 7 time(s). The most recent filing (Q2 2026) shows 195,878 shares valued at US$815K. Notable position changes include a 236% increase in Q4 2023 (shares rose 82% over the following quarter), a 59% trim in Q1 2024 (shares fell 46% over the following quarter), a 98% increase in Q2 2024 (shares rose 17% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 95.40K | $434.07K | New |
| Q4 2023 | 320.28K | $2.60M | Add |
| Q1 2024 | 131.59K | $1.95M | Reduce |
| Q2 2024 | 261.09K | $2.09M | Add |
| Q3 2024 | 261.09K | $2.45M | Hold |
| Q4 2024 | 261.09K | $1.93M | Hold |
| Q1 2025 | 195.88K | $652.27K | Reduce |
| Q2 2025 | 195.88K | $336.91K | Hold |
| Q3 2025 | 195.88K | $425.06K | Hold |
| Q4 2025 | 195.88K | $534.75K | Hold |
| Q1 2026 | 195.88K | $687.53K | Hold |
| Q2 2026 | 195.88K | $814.85K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IOVA and 13F data
IOVA (IOVANCE BIOTHERAPEUTICS INC) is a Health Care company. 28 other funds we track also report a position in IOVA — the largest reported positions include MHR FUND MANAGEMENT LLC (US$120.5M), Palo Alto Investors LP (US$22.0M), Mirador Capital Partners LP (US$16.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IOVA
- MHR FUND MANAGEMENT LLC 28.97M sh · $120.50M · Q2 2026
- Palo Alto Investors LP 5.30M sh · $22.03M · Q2 2026
- Mirador Capital Partners LP 1.10M sh · $16.24M · Q3 2026
More on Parametrica Management Ltd
FAQ
How long has Parametrica Management Ltd held IOVA?
Parametrica Management Ltd has disclosed IOVA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Parametrica Management Ltd's current position in IOVA?
As of Q2 2026, Parametrica Management Ltd holds 195.88K shares of IOVA (IOVANCE BIOTHERAPEUTICS INC), valued at $814.85K, representing 0.64% of its reported portfolio and ranking #18.
Has Parametrica Management Ltd been buying or selling IOVA?
In the latest 13F filing (Q2 2026), Parametrica Management Ltd held unchanged its position in IOVA. The position peaked in Q4 2023 at 320.28K shares.
Which other funds hold IOVA?
Other major institutional holders of IOVA include MHR FUND MANAGEMENT LLC, Palo Alto Investors LP, Mirador Capital Partners LP, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.